Canadian Pharmacy Finds Optimum Blood Sugar Control Does Not Stop Dementia

Millions of Americans suffer from type 2 diabetes, and many others are not even aware they run the risk of getting it without making some basic lifestyle changes. Our Canadian pharmacy thinks there is a need to worry, as researchers have now found patients suffering from type 2 diabetes cannot reverse loss of memory just by exercising strict control over blood sugar levels.

Recent studies published in Lancet Neurology point out people have a higher risk of facing death by trying to control blood sugar strictly. Findings must be evaluated in context to earlier research indicating stringent blood sugar control in diabetics helped avoid complications such as cardiovascular diseases, kidney and vision problems. Researchers had earlier not established decline in cognitive powers due to strict control.

Research findings does complicate matters, as it also establishes type 2 diabetics over the age of 70 years have double the risk of developing an accelerated rate of dementia when compared to people in the same age group without type 2 diabetes.

The Laboratory of Epidemiology, Demography and Biometry based at U.S. National Institute on Aging conducted research on 2,977 people aged between 55 to 80 years and suffering from type 2 diabetes. Additionally, they were diagnosed with high risk of developing heart disease on taking part in the program Action to Control Cardiovascular Risk in Diabetics (ACCORD). Treatment plans consisted of either lowering blood sugar levels or sustaining optimum control with standard treatment plans. The study identified 614 participants for MRI scans to measure brain volume. The MRI scan group also completed cognitive ability tests before and after analysis.

Blood sugar levels in diabetics are usually maintained between 7 to 7.5% measured through an A1c test points out Canada Pharmacy. However, analysis in the current study was based on lowering blood sugar levels to below 6% and then following up on the results. Over a period of roughly 3 years and four months, follow-up tests did not indicate any difference in cognitive ability measurements even though the tighter blood control group demonstrated bigger brain volume as compared to patients on the standard treatment plan. People generally buy Actos for the treatment of type 2 diabetes.

Observations during follow-up led to the discovery that patients ran a higher risk of facing death because of complications arising from decreased blood sugar levels and excess weight gain. It resulted in premature termination of the tests, as it was evident there was no measurable benefit in terms of improved cognitive levels. Control over sugar on a regular basis based on standard therapy was therefore suggested to avoid medical complications over the long term.

Larger brain volume did not imply better cognitive powers. There is a need to be more conscious of pre-diabetes, especially in people over the age of 50 years. The purpose of controlling blood sugar must be to avoid medical conditions that arise in uncontrolled diabetes. Recent research does not encourage too many changes to be made in the medical regimen.

Canada pharmacy recommends standard medical procedures be followed to control blood sugar levels in people suffering from type 2 diabetes. It is better to make necessary lifestyle changes to exercise greater control as well as improve quality of life.